Literature DB >> 7980607

Internalization of the type I angiotensin II receptor (AT1) is required for protein kinase C activation but not for inositol trisphosphate release in the angiotensin II stimulated rat adrenal zona glomerulosa cell.

S Kapas1, J P Hinson, J R Puddefoot, M M Ho, G P Vinson.   

Abstract

A specific antibody, 6313/G2, to the N-terminus of the angiotensin II type I (AT1) receptor causes retention of the AT1 receptor in the plasma membrane of rat adrenal zona glomerulosa cells and stimulates steroidogenesis and inositol trisphosphate (IP3) release. Its effects are not significantly additive with those of angiotensin. In contrast, 6313/G2 completely inhibits angiotensin induced translocation of protein kinase C to the membrane fraction, although alone it has no effect. The data suggest that IP3 linked events, such as steroidogenesis, do not require receptor internalization, but protein kinase C activation does. They also confirm that protein kinase C activation is not required for stimulation of steroidogenesis in rat dispersed glomerulosa cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7980607     DOI: 10.1006/bbrc.1994.2603

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

Review 1.  Molecular biology of angiotensin receptors and their role in human cardiovascular disease.

Authors:  V Regitz-Zagrosek; M Neuss; J Holzmeister; C Warnecke; E Fleck
Journal:  J Mol Med (Berl)       Date:  1996-05       Impact factor: 4.599

Review 2.  Angiotensin II: biosynthesis, molecular recognition, and signal transduction.

Authors:  J F Riordan
Journal:  Cell Mol Neurobiol       Date:  1995-12       Impact factor: 5.046

3.  Dependence of agonist activation on a conserved apolar residue in the third intracellular loop of the AT1 angiotensin receptor.

Authors:  L Hunyady; M Zhang; G Jagadeesh; M Bor; T Balla; K J Catt
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.